| A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
HIV‐1 RNA, Qualitative Real‐Time PCR : 16185
Test CodeHIV1QL or 16185
CPT Codes
87535.
Includes
Instructions
Separate plasma or serum from the cells by centrifugation within 24 hours aftercollection. Transfer the specimen to a plastic screw‐cap vial. Separated plasma or serum can be sent in the PPT/SST but cannot be shipped frozen.
Transport Container
Preferred Specimen
1.6 mL serum or plasma collected in an EDTA (lavender-top) tube or potassium EDTA (white-top) tube
Minimum Volume
0.6 mL
1.6 mL serum or plasma collected in an EDTA (lavender-top) tube or potassium EDTA (white-top) tube
Minimum Volume
0.6 mL
Transport Temperature
Frozen.
Specimen Stability
Room temperature: 72 hours; Refrigerated: 5 days; Frozen: 6 weeks
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Frozen PPT or SST tube.
Methodology
Real-Time Polymerase Chain Reaction (RT-PCR)
Setup Schedule
Sunday - Saturday
Report Available
1-2 days
Reference Range
Not Detected
Clinical Significance
HIV‐1 Qualitative is an in vitro nucleic acid amplification test for the qualitative
detection of human immunodeficiency virus type 1 (HIV‐1) RNA in human serum and
plasma by PCR. The test is intended to be used as an aid in diagnosis of HIV‐1
infection. Detection of HIV‐1 nucleic acid is indicative of HIV‐1 infection. The
presence of HIV‐1 nucleic acid in the plasma or serum of individuals without
antibodies to HIV‐1 is indicative of acute or primary HIV‐1 infection. The HIV‐1
Qualitative PCR may also be used as an additional test to confirm the presence of
HIV‐1 infection in an individual with specimens reactive for HIV‐1 antibodies or
antigens. The assay may also be used as an aid in the diagnosis of infection with HIV‐
1 in pediatric subjects and pregnant women. This assay is not intended to be used
for monitoring patient status, or for screening donors of blood, plasma, or human
cells, tissues, and cellular and tissue‐based products (HCT/Ps) for HIV.
detection of human immunodeficiency virus type 1 (HIV‐1) RNA in human serum and
plasma by PCR. The test is intended to be used as an aid in diagnosis of HIV‐1
infection. Detection of HIV‐1 nucleic acid is indicative of HIV‐1 infection. The
presence of HIV‐1 nucleic acid in the plasma or serum of individuals without
antibodies to HIV‐1 is indicative of acute or primary HIV‐1 infection. The HIV‐1
Qualitative PCR may also be used as an additional test to confirm the presence of
HIV‐1 infection in an individual with specimens reactive for HIV‐1 antibodies or
antigens. The assay may also be used as an aid in the diagnosis of infection with HIV‐
1 in pediatric subjects and pregnant women. This assay is not intended to be used
for monitoring patient status, or for screening donors of blood, plasma, or human
cells, tissues, and cellular and tissue‐based products (HCT/Ps) for HIV.
Performing Laboratory
med fusion
